1-1295453-G-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_030649.3(ACAP3):c.1807C>A(p.Pro603Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000249 in 1,612,304 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00017 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00026 ( 0 hom. )
Consequence
ACAP3
NM_030649.3 missense
NM_030649.3 missense
Scores
2
4
13
Clinical Significance
Conservation
PhyloP100: 7.70
Genes affected
ACAP3 (HGNC:16754): (ArfGAP with coiled-coil, ankyrin repeat and PH domains 3) Predicted to enable GTPase activator activity and metal ion binding activity. Predicted to be involved in regulation of catalytic activity. Predicted to act upstream of or within neuron migration and regulation of neuron projection development. Predicted to be located in growth cone. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.40704697).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACAP3 | NM_030649.3 | c.1807C>A | p.Pro603Thr | missense_variant | 19/24 | ENST00000354700.10 | NP_085152.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACAP3 | ENST00000354700.10 | c.1807C>A | p.Pro603Thr | missense_variant | 19/24 | 1 | NM_030649.3 | ENSP00000346733.5 | ||
ACAP3 | ENST00000353662.4 | c.1681C>A | p.Pro561Thr | missense_variant | 17/21 | 1 | ENSP00000321139.4 | |||
ACAP3 | ENST00000467278.5 | n.1333C>A | non_coding_transcript_exon_variant | 9/14 | 1 | |||||
ACAP3 | ENST00000492936.5 | n.3546C>A | non_coding_transcript_exon_variant | 18/22 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152180Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
26
AN:
152180
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000181 AC: 45AN: 248576Hom.: 0 AF XY: 0.000178 AC XY: 24AN XY: 135142
GnomAD3 exomes
AF:
AC:
45
AN:
248576
Hom.:
AF XY:
AC XY:
24
AN XY:
135142
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000257 AC: 375AN: 1460124Hom.: 0 Cov.: 33 AF XY: 0.000266 AC XY: 193AN XY: 726354
GnomAD4 exome
AF:
AC:
375
AN:
1460124
Hom.:
Cov.:
33
AF XY:
AC XY:
193
AN XY:
726354
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000171 AC: 26AN: 152180Hom.: 0 Cov.: 34 AF XY: 0.000175 AC XY: 13AN XY: 74332
GnomAD4 genome
AF:
AC:
26
AN:
152180
Hom.:
Cov.:
34
AF XY:
AC XY:
13
AN XY:
74332
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
22
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 13, 2022 | The c.1807C>A (p.P603T) alteration is located in exon 19 (coding exon 19) of the ACAP3 gene. This alteration results from a C to A substitution at nucleotide position 1807, causing the proline (P) at amino acid position 603 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;T
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
D;D
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at